Insight on an Arginine Synthesis Metabolon from the Tetrameric Structure of Yeast Acetylglutamate Kinase by de Cima, Sergio et al.
Insight on an Arginine Synthesis Metabolon from the
Tetrameric Structure of Yeast Acetylglutamate Kinase
Sergio de Cima
1, Fernando Gil-Ortiz
1, Marjolaine Crabeel
2, Ignacio Fita
3*, Vicente Rubio
1*
1Instituto de Biomedicina de Valencia del Consejo Superior de Investigaciones Cientı ´ficas (IBV-CSIC), Centro de Investigacio ´n Biome ´dica en Red de Enfermedades Raras
(CIBERER-ISCIII), Valencia, Spain, 2Department of Genetics and Microbiology Emeritus, Vrije Universiteit, Brussel, Belgium, 3Instituto de Biologia Molecular de Barcelona
IBMB-CSIC/Institute of Research in Biomedicine (IRB-Barcelona), Parc Cientific, Barcelona, Spain
Abstract
N-acetyl-L-glutamate kinase (NAGK) catalyzes the second, generally controlling, step of arginine biosynthesis. In yeasts,
NAGK exists either alone or forming a metabolon with N-acetyl-L-glutamate synthase (NAGS), which catalyzes the first step
and exists only within the metabolon. Yeast NAGK (yNAGK) has, in addition to the amino acid kinase (AAK) domain found in
other NAGKs, a ,150-residue C-terminal domain of unclear significance belonging to the DUF619 domain family. We
deleted this domain, proving that it stabilizes yNAGK, slows catalysis and modulates feed-back inhibition by arginine. We
determined the crystal structures of both the DUF619 domain-lacking yNAGK, ligand-free as well as complexed with
acetylglutamate or acetylglutamate and arginine, and of complete mature yNAGK. While all other known arginine-
inhibitable NAGKs are doughnut-like hexameric trimers of dimers of AAK domains, yNAGK has as central structure a flat
tetramer formed by two dimers of AAK domains. These dimers differ from canonical AAK dimers in the 2110u rotation of
one subunit with respect to the other. In the hexameric enzymes, an N-terminal extension, found in all arginine-inhibitable
NAGKs, forms a protruding helix that interlaces the dimers. In yNAGK, however, it conforms a two-helix platform that
mediates interdimeric interactions. Arginine appears to freeze an open inactive AAK domain conformation. In the complete
yNAGK structure, two pairs of DUF619 domains flank the AAK domain tetramer, providing a mechanism for the DUF619
domain modulatory functions. The DUF619 domain exhibits the histone acetyltransferase fold, resembling the catalytic
domain of bacterial NAGS. However, the putative acetyl CoA site is blocked, explaining the lack of NAGS activity of yNAGK.
We conclude that the tetrameric architecture is an adaptation to metabolon formation and propose an organization for this
metabolon, suggesting that yNAGK may be a good model also for yeast and human NAGSs.
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Introduction
Microorganisms and plants make arginine from glutamate using
a route in which intermediates are N-acetylated (Figure 1). The
first step of the route is the production of N-acetyl-L-glutamate
(NAG), while the second is the phosphorylation of NAG by NAG
kinase (NAGK) [1,2]. In some organisms like Escherichia coli this
route is linear and NAG is made from acetyl CoA (AcCoA) and
glutamate by NAG synthase (NAGS). However, many other
organisms recycle the acetyl group by transacetylation from N-
acetylornithine to glutamate (Figure 1), while the feedback control
of the route by arginine is exerted at the NAGK level [1–3]. The
regulatory importance of NAGK is highlighted by the fact that, in
photosynthetic organisms, this enzyme is the target of PII,a
signaling protein that orchestrates metabolic adaptations to
nitrogen/carbon abundance [4,5]. By binding to NAGK when
ammonia is abundant, PII relieves NAGK from arginine inhibition
and allows nitrogen to stockpile as arginine [4,5].
Because of the paramount regulatory role of NAGK, this
enzyme has been the focal point of studies which have revealed the
structures of the arginine-insensitive NAGK of E. coli [6] and of
arginine-sensitive NAGKs from bacteria and from the plant
Arabidopsis thaliana [7–9] either alone or complexed with PII.
NAGK presents a typical subunit fold which is considered the
paradigm of the amino acid kinase (AAK) family [6]. This fold
consists of a characteristic a3b8a4 sandwich with a mostly parallel
central b8-sheet, which is split into N- and C-lobes. All the
NAGKs characterized structurally so far [6–9] are composed of
identically shaped homodimers, in which the central b-sheet
becomes continuous across the intersubunit junction due to
contacts between the antiparallel b5 strands of the two subunits.
Nevertheless, the structurally characterized NAGKs that are the
subject of feedback inhibition by arginine have an extra N-
terminal kinked a-helix, which links the NAGK dimers into
doughnut-like hexamers with D3 symmetry [7–9]. Arginine binds
at the interdimeric junctions next to these N-terminal helices and
is believed to inhibit NAGK by expanding the hexameric ring,
separating the two lobes of each subunit, thus preventing catalysis
[7–9].
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34734We report here structural and functional studies on the
arginine-sensitive NAGK from Saccharomyces cerevisiae (yNAGK).
This enzyme, which is produced in yeast mitochondria by
proteolytic processing of the polyprotein precursor (Uniprot
database code Q01217) encoded by the ARG5,6 gene, has the
unexplained peculiarity, which is shared by the NAGKs of other
ascomycetes, of having, in addition to the AAK domain, a C-
terminal domain of ,150 residues of unknown structure and
function (Figure 2A) [10–12]. The same type of domain is found at
the C-terminus in the NAGSs of ascomycetes and animals,
including humans [13,14]. This domain belongs to the DUF619
domain family (where DUF stands for domain of unknown
function) of the Pfam (http://pfam.sanger.ac.uk) and InterPro
(http://www.ebi.ac.uk/interpro) databases. Another very interest-
ing characteristic of yNAGK is that it forms with yeast NAGS
(yNAGS) a complex with the features of a true metabolon [12,15],
with its NAGS and NAGK components mutually influencing their
regulatory properties by arginine [15] (Figure 1). Furthermore,
whereas yNAGK can exist independently of yNAGS, the latter
enzyme can exist only as a part of the NAGK/NAGS metabolon
[12,15]. Thus, yNAGK may also act as a chaperone and/or an
essential stabilizing agent for yNAGS. Since ascomycetal NAGK
and NAGS are homologous enzymes, which apparently exhibit
the same domain organization [14], the ascomycetal NAGK/
NAGS metabolon may have evolved from an ancestral oligomer
formed by a single bifunctional enzyme molecule displaying both
NAGK and NAGS activities. Such a bifunctional enzyme has
been recently identified in Xanthomonas campestris [14].
Figure 1. Arginine biosynthesis pathway of Saccharomyces cerevisiae. The kinase activity of the metabolon is inhibited by lower
concentrations of arginine than N-acetyl-L-glutamate kinase alone. Red broken arrows indicate inhibition by arginine.
doi:10.1371/journal.pone.0034734.g001
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of ascomycetal NAGKs, we carried out in vitro expression and
crystallographic studies of yNAGK. We demonstrated a modula-
tory and stabilizing role of the DUF619 domain on yNAGK. The
structure of the mature yNAGK, lacking the N-terminal
mitochondrial targeting sequence (residues 1–57 [12]), reveals an
unexpected novel tetrameric architecture, which can be described
as a dimer of dimers with D2 symmetry. The AAK domains
occupy the center of the molecule flanked by two pairs of
interacting DUF619 domains. A crystal, in which an arginine
molecule is bound to one subunit, gives a snapshot of arginine-
complexed and arginine-free subunits, which supports the
previously proposed mechanism of arginine inhibition [7,9]. The
structure of the DUF619 domain reveals a histone acetyltransfer-
ase fold (GNAT domain fold) [16] in which the site for AcCoA is
blocked. The yNAGK structure might help model that of human
NAGS, an enzyme deficiencies in which cause inherited clinical
hyperammonemia [13]. The structure also allows to propose a
model for the NAGK/NAGS complex forming the yeast
metabolon.
Results and Discussion
Roles of the DUF619 domain in yNAGK
A truncated form of yNAGK spanning from residue 58 to 356,
corresponding to the AAK domain and lacking the C-terminal
Figure 2. Yeast NAGK domain composition and effects of DUF619 domain deletion. (A) yNAGK domain composition and purification of
the recombinant complete enzyme and its two isolated domains. Left, Coomassie-stained SDS-PAGE of the purified proteins. St; molecular markers,
with masses given at the side. Right, bar representation of the domain composition of the whole enzyme and of the isolated domain constructs, with
residue numbers. The mitochondrial signal peptide (faint tracing) was not included in the constructs. Both expressed domains are shown in different
gray shades. For the isolated GNAT domain, the sequence was extended C-terminally to its potential maximum, corresponding to the beginning of
the next enzyme encoded by the polyprotein precursor. The masses in kDa of the recombinant polypeptide chains, including their tags, are the
following: yNAGK, 51; truncated AAK, 34; GNAT domain, without or after His-tag cleavage, 21.6 and 19.7 respectively. (B) and (C) Substrate kinetics for
NAG and ATP. The results from the enzyme activity assays (see Materials and Methods; points are means 6 standard errors (SE) for at least three
determinations) were fitted in the case of the data for ATP and NAG to hyperbolae, except for the NAG kinetics for truncated yNAGK (AAK), which was
fitted to hyperbolic kinetics with substrate inhibition according to the equation [52]: v~V|½S 7(½S zKmz½S 
27Ki)))))  . The inset tables provide
means 6 SE for the indicated parameters. kcat values are given per polypeptide chain. (D) Arginine inhibition kinetics. The results were fitted to
sigmoidal inhibition according to equation [3]:v Arg jj ~v½Arg {0|(1{ ½Arg 
N7(IN
0:5z½Arg 
N)
  
), where N is the Hill coefficient and I0.5 is the
arginine concentration which gives 50% inhibition. The inset table gives the I0.5 and N values (means 6 SE). (E) and (F) Thermofluor assays with NAGK
and its isolated domains. When used, L-arginine was at a concentration of 50 mM. For further details, see Materials and Methods.
doi:10.1371/journal.pone.0034734.g002
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)DUF619 domain, was produced as a soluble protein in milligram
amounts in E. coli (see Materials and Methods and Figure 2A).
Deletion of the DUF619 domain did not impair activity or
arginine inhibition, as expected from the absence of a similar
domain in bacterial and plant NAGKs [6–9]. In fact, the
truncated yNAGK was even more active than the complete
enzyme, as the deletion almost doubled the apparent kcat, whereas
the Km values for the two substrates, NAG and ATP, were little
affected (Figures 2B and 2C). Thus, the binding sites for both
substrates and the active center itself sit entirely within the AAK
domain of yNAGK, while the presence of the DUF619 domain
somewhat inhibits catalysis. In the truncated protein, the
sensitivity to arginine is increased (Figure 2D), since the arginine
concentration causing 50% inhibition (I0.5) was lowered, while the
dependency of activity on arginine concentration was no longer
sigmoidal. The sigmoidal nature of the arginine inhibition of the
complete enzyme is an important attribute, making the enzyme
little sensitive to low arginine concentrations but allowing the
inhibition to escalate rapidly when the arginine concentration
exceeds a given threshold. Therefore, the DUF619 domain exerts
a modulatory effect on arginine inhibition which may prove
important in vivo. Interestingly, the effects of DUF619 deletion on
arginine inhibition kinetics replicate those observed when NAGK
associates with NAGS in the NAGK/NAGS metabolon [15]
(Figure 1), suggesting that the DUF619 domain is prevented from
modulating NAGK inhibition in the metabolon.
An important stabilizing role of the DUF619 domain has been
demonstrated in thermofluor unfolding studies [17] (Figures 2E
and 2F). In these assays, the isolated DUF619 domain, produced
recombinantly (Figure 2A), was approximately as stable as the
complete enzyme (T0.5 values of 52uC and 49uC, respectively),
whereas the truncation of the enzyme decreased its thermal
stability by ,10uC. The results also revealed a stabilizing effect, by
approximately 4uC, of arginine on the complete enzyme, but
particularly on the isolated AAK domain (T0.5 values of 39uC and
51uC in the absence and the presence of arginine, respectively), to
the extent that the unfolding of this domain became virtually
indistinguishable from that of the complete enzyme when arginine
was present (Figure 2E). In contrast, arginine had no stabilizing
effect (Figure 2F) on the DUF619 domain, thus confirming that
the binding site for arginine is located in the AAK domain.
yNAGK and its isolated DUF619 domain lack NAGS
activity
The bifunctional NAGS-NAGK of X. campestris has been
reported [14] to have the same domain organization as yNAGK,
with both enzymes exhibiting comparable NAGK activities (1.95
and 3.31 U/mg, respectively). However, while the X. campestris
enzyme is a very active NAGS having a specific activity of 76 U/
mg, we did not detect (detection limit, ,0.2 U/mg) any NAGS
activity [18] with yNAGK in either pH 7 or 9, which is considered
optimal for NAGSs, or in the presence or absence of MgATP,
addressing the possibility of strict coupling between the potential
NAGS activity and the NAGK activity. In contrast, the yeast
NAGS/NAGK complex (data not shown) or the NAGS from
Pseudomonas aeruginosa were very active NAGSs, having activities of
250 U/mg (pH 9, 37uC) or 79 U/mg (pH 9, 37uC [18]),
respectively.
Recently, NAGS activity has been demonstrated with an NAGS
of Mycobacterium tuberculosis [19] consisting exclusively of an isolated
acetyltransferase domain that resembles the C-terminal domain of
classical bacterial NAGSs [20], which is also similar to the
DUF619 domain of yNAGK (see below). Thus, it is conceivable
that the potential NAGS activity of the DUF619 domain of
yNAGK might be repressed by the presence of the AAK domain,
and that this domain in the NAGK/NAGS metabolon might be
released from inhibition. However, constructs of the isolated
DUF619 domain, with or without a His-tag (Figure 2A), did not
exhibit even traces of NAGS activity at either pH 7 or pH 9
(detection limit, 0.1 U/mg). In contrast, and as a control of the
assay, activity was observed with the NAGS from M. tuberculosis
(1.5 U/mg at 0.1 M L-glutamate, pH 9; unpublished data from
ML. Ferna ´ndez-Murga in our laboratory). In summary, and in
agreement with prior genetic evidence (reviewed in [12]) and with
the results of assays in crude mixtures [15], yNAGK does not
appear to be a bifunctional NAGK/NAGS.
Structure of truncated yNAGK
Four crystal structures of truncated yNAGK, ligand-free or
complexed with either NAG or NAG and arginine, were
determined using for the initial phasing single anomalous
diffraction (SAD) from a Se-Met derivative (Table 1). Four
subunits, organized as a dimer of dimers with D2 local symmetry,
were found in the asymmetric unit of these crystals (Tables 1, 2
and Figure 3A). Given the fact that prior structures of arginine-
sensitive NAGKs correspond to D3 hexamers (Figure 3B) [7–9], a
tetrameric architecture was unexpected, but it was supported by
size exclusion chromatography of both the truncated and the
complete mature yNAGK proteins. The elution profiles of these
proteins were more consistent with tetramers than hexamers
(Figure 4). The small peaks observed to elute earlier with both the
truncated and the complete yNAGK were consistent with
octamers (possibly aggregates of two tetramers) rather than with
dodecamers (aggregates of two hexamers) (Figure 4).
Despite the different oligomerization of yNAGK in relation to
other NAGKs, the AAK domain structure closely conforms to the
canonic a3b8a4 sandwich NAGK subunit fold [6–9] (Figure 5A),
with the N-lobe spanning residues 96–272 and the C-lobe residues
273–350. Even the lengths of the loops and of the secondary
structure elements are similar to those of E. coli NAGK (EcNAGK)
(root mean square deviation, r.m.s.d., 1.8 A ˚ for superimposition of
246 Ca atoms). In the crystals containing NAG, one NAG
molecule was found in each subunit (Figure 5B). As reported in
other NAGKs (best studied in EcNAGK [6]), NAG is bound in a
pocket in the N-lobe under the closed lid formed by the b3–b4
hairpin (Figures 5B and 5C). In the structure of the truncated
yNAGK without NAG (resolution 2.95 A ˚, Tables 1, 2), the lid is
observed in two different open conformations, which are, however,
less open than in the structure of the NAG-free EcNAGK [21]
(Figure 5C). Although no ATP-containing crystals were obtained,
the ATP site is patent in the C-lobe at its expected location
(Figure 5A) [6]. In fact, all the residues considered important for
ATP binding and for catalysis are conserved as, for example,
glycines 106, 137, 274 and 305, catalytic lysines 103 and 309, and
the intervening aspartate 251, which correspond to EcNAGK
glycines 11, 45, 184 and 213, lysines 8 and 217, and aspartate 162,
respectively [6]. In summary, the subunit core fold, the substrate
binding sites, the active center and the catalytic mechanism appear
essentially identical in the AAK domain of yNAGK and in
EcNAGK. In contrast with this high similarity of the AAK
domains, the three possible dimers which could be defined in
yNAGK by the three molecular axes PQR (Figure 3A) differ from
those in other NAGKs. Nevertheless, the R dimer of yNAGK uses
for dimer formation the same subunit surface, which is used by
other NAGKs, although with a 2110u relative rotation between
the subunits around an axis perpendicular to the interacting
surfaces (Figures 3A and 3B, top insets; and Figure S1). As already
indicated, in canonic NAGKs the central b-sheet extends across
Structure of Yeast Acetylglutamate Kinase
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two subunits (Figure 3B top inset). In yNAGK, the b5 strands of
the two subunits still interact with each other, although they are
parallel due to the large rotation of one subunit relative to the
other (Figures 3A top inset, and 3C). Helices C and D, which
sandwich b5, run parallel to the corresponding helices from the
adjacent subunit, instead of forming the cross-grid observed with
other NAGKs (Figures 3A and 3B top insets). Overall, the total
occluded surface at the R interface, of 1044 A ˚ 2 per subunit as
determined with the PISA server (see Methods), is divided into two
approximately equal patches - one towards each end of helix C -
leaving a non-interacting central region between these patches. As
illustrated by the top dimer in the tetramer shown in Figure 3A,
this R dimer of the yNAGK AAK domains has a butterfly-like
shape and is flatter and more continuous around the molecular
two-fold R axis than in canonic NAGKs.
Arginine-sensitive NAGKs, including yNAGK, have a 19–38
residue-long N-terminal extension which is responsible for joining
the dimers into the corresponding oligomers [7]. In the hexameric
NAGKs, this N-terminal extension (residues 1 to 25 in P. aeruginosa
NAGK) consists of a protruding, slightly kinked helix that
interlaces with the same helix of another subunit from a different
dimer (Figure 3B and its bottom inset) [7–9]. However, in yNAGK
the N-terminal extension comprises two helices forming an angle
of approximately 45u, and a 5-residue N-terminal extended coil.
These three elements form a platform or ‘‘stand’’ which mediates
and determines the interactions between the dimers across the Q
axis of the tetramer (Figure 3A, labeled ‘‘interdimeric junction’’).
At each interdimeric junction, a four-helix bundle is formed by
both interacting ‘‘stands’’, burying an approximate area of 910 A ˚ 2
per subunit. The bundle is stabilized mainly by hydrophobic
interactions involving V71, I72, L75, V84, L88, and F91, but also
by hydrogen bonds linking R68 and F91, and linking K81 with
N76 and I78 (see Figure S2). Each ‘‘stand’’ is connected to the
body of its cognate subunit by a large array of interactions, in
particular with the C-ends of helices A and H and the adjacent
loops, which are mainly hydrophobic and include several aromatic
residues (Figures 3A and S2). This extensive network of
interactions still allows conformational changes of one of the
‘‘stands’’ without junction dissociation, as when arginine was
bound to one subunit (see below), and as reflected in the slightly
different positions of the ‘‘stands’’ in different subunits. In any
Table 1. Crystallographic data collection.*
Parameter yNAGK lacking its C-terminal domain Complete yNAGK
Se-Met-substituted NAG-containing
Arginine-
soaked No ligands Crystal 1
a Crystal 2
a Crystal 3
Beamline ESRF ID14-4 ID14-4 BM16 ID14-4 ID14-4 ID14-4 ID23-2
Wavelength (A ˚) 0.9790 0.9393 0.9786 0.9393 0.9393 0.9393 0.8726
Space group P212121 P212121 P212121 P212121 C2 P1 P1
Unit cell parameters
a( A ˚) 69.8 69.7 69.5 68.1 112.0 95.2 92.3
b( A ˚) 99.2 99.3 99.6 100.5 146.7 111.3 103.3
c( A ˚) 189.8 190.6 189.2 188.7 70.7 113.1 111.3
a (deg) 90.0 90.0 90.0 90.0 90.0 75.8 77.3
b (deg) 90.0 90.0 90.0 90.0 101.4 89.3 89.3
c (deg) 90.0 90.0 90.0 90.0 90.0 69.1 70.4
Solvent (%) 49 49 49 48 56 53 49
Resolution range (A ˚) 87.7–3.4 20–2.2 20–2.1 20–2.95 87.9–3.1 109–3.8 108–3.25
(3.6–3.4) (2.3–2.2) (2.2–2.1) (3.1–2.95) (3.3–3.1) (4.0–3.8) (3.43–3.25)
Total reflections 216123 1015192 372634 178140 46836 94503 109862
Unique reflections 18793 67865 77012 28023 19757 39773 57473
I/sI 4.9 (2.7) 5.0 (1.9) 3.8 (1.9) 8.3 (2.1) 9.3 (2.0) 10.5 (1.5) 9.6 (1.7)
Rsym
b (%) 13.2 (24.8) 12.0 (40.5) 13.1 (36.7) 6.8 (37.3) 6.3 (34.7) 5.7 (45.5) 7.0 (45.6)
Completeness (%) 100 (100) 100 (100) 99.6 (99.6) 99.8 (99.8) 97.6 (97.6) 96.3 (96.3) 96.2 (96.2)
Wilson B factor (A ˚2) 41.5 26.7 19.8 79.7 86.8 97.4 72.2
Multiplicity 11.5 (11.9) 15.0 (15.3) 4.8 (4.7) 6.4 (6.5) 2.4 (2.4) 2.4 (2.4) 1.9 (1.9)
Phasing statistics for Se-Met
substit.
Se atoms 20 - - - - - -
FOM
c 0 . 7 6 2 - -- -- -
CC all/weak
d (%) 43.1/21.2 - - - - - -
*Values in parentheses are the data for the highest resolution shell.
aData ellipsoidal truncation and anisotropic scaling were applied using the UCLA MBI Diffraction Anisotropy Server [54] to correct for strong anisotropy.
bRsym~
P
I{vIw jj 7
P
I, where I is the observed intensity, and ,I. is the average intensity of the multiple observations of symmetry-related reflections.
cFigure of merit after density modification.
dCorrelation coefficient all/weak as defined by program SHELX.
doi:10.1371/journal.pone.0034734.t001
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association of two yNAGK dimers into a relatively flat rectangular
tetramer with approximate dimensions of 35 A ˚6109 A ˚683 A ˚.
This tetramer is perforated by a central hole of 18 A ˚ diameter,
which is formed between the two domain bodies and the two
interdimeric junctions. Two active centers, separated by a distance
of 80 A ˚, are exposed in one diagonal on each face of the tetramer
(Fig. 3A).
Structural changes triggered by arginine and the arginine
inhibition mechanism
Whereas one normally bound NAG molecule was found sitting
in each subunit of the yNAGK tetramer of the arginine-soaked
crystal (resolution, 2.1 A ˚; Tables 1 and 2), only one subunit
contained bound arginine. The arginine molecule sits where
expected [7,9], at the free end of the C-lobe, between the second
N-helix, the central b sheet, helix H and the loop connecting this
helix to b16 (Figures 3A, 6A and 6B). There are important
conformational differences between the arginine-containing and
the arginine-free subunits (Figure 6C). In the arginine-containing
subunit the C-lobe of the AAK domain has moved away from the
N-lobe, around a hinge located at the interlobar boundary
(residues V267-Y268). This movement can be described as a 16u
rigid-body rotation of the C-lobe about an axis that crosses
obliquely the central b sheet at the level of b11 (Figure 6C). A
similar open conformation has been reported in arginine-bound
hexameric NAGKs [7,9] and, with somewhat different character-
istics, in substrate-free EcNAGK [21]. In the open conformation,
the active center is distorted, with the sites for the two substrates
being separated, thus likely corresponding to an inactive enzyme
form [21]. Therefore, these results support the view that arginine,
by binding to both the second N-helix and the C-lobe, pulls the C-
lobe away from the N-lobe, which is firmly anchored to the other
subunit of the R dimer, stabilizing the open inactive conformation
of the AAK domain, thus causing the inhibition.
Arginine binding is also associated with structural changes in the
second N-helix, which, in the arginine-free subunits, is dislodged
from the arginine binding site by a displacement of 4.5 A ˚
(maximum displacement of a Ca atom, 8 A ˚) and a rotation of
25u about its central axis (Figure 6B). These changes in the
arginine binding site are not propagated across the interdimeric
junction, which thus becomes nonsymmetric (Figure 3A), explain-
ing the lack of cooperativity for arginine inhibition of truncated
yNAGK (Figure 2D). Changes at the arginine binding site
diminish the buried surface at the interdimeric junction of
yNAGK from 910 A ˚ 2 per subunit in the arginine-lacking
tetramers to 840 and 800 A ˚ 2 in the arginine-containing and
arginine-free subunits, respectively. However, as the stability of the
truncated enzyme is remarkably increased by arginine (Figure 2E),
Table 2. Refinement statistics.
yNAGK lacking its C-terminal domain Complete mature yNAGK
NAG-containing Arginine-soaked No ligands Crystal 2 Crystal 3
PDB code 3ZZF 3ZZH 3ZZG 3ZZI 4AB7
Resolution range (A ˚) 20–2.20 20–2.10 20–2.95 65.95–3.80 108.3–3.25
Reflections, work/test 64245/3432 72907/3860 26458/1398 37381/1985 54576/2896
Rfactor,
a work/test (%) 17.87/21.81 18.04/21.54 21.19/24.52 19.72/23.59 19.27/23.76
Average B-factors (A ˚2)
Protein atoms 26.5 22.3 81.4 127.6 93.3
NAG 23.1 14.4 - - 72.7
Arginine - 29.3 - - -
H g 4 3 . 6 ----
Water 14.5 13.7 - - -
Number of:
P o l y p e p t i d e c h a i n s 4 4488
Protein atoms 9107 9059 8978 27248 26294
NAG molecules 4 4 - - 2
Arginine molecules - 1 - - -
H g a t o m s8 ----
Water molecules 430 497 - - -
RMSD bond (A ˚) 0.008 0.007 0.009 0.016 0.014
RMSD angle (u) 1.04 1.02 1.08 1.79 1.76
Ramachandran plot
b (%)
Most favored 94.1 94.0 91.3 87.8 85.7
Additionally allowed 5.2 5.3 7.8 11.9 13.3
Generously allowed 0.7 0.5 0.6 0.3 1.0
Disallowed 0.0 0.2 0.4 0.0 0.0
aRfactor~
P
hkl Fobsj{ Fcalc j kk 7
P
hkl Fobs jj where Fobs and Fcalc are the observed and calculated structure factors, respectively.
bCalculated using PROCHECK.
doi:10.1371/journal.pone.0034734.t002
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e34734Figure 3. Structure of yNAGK lacking its DUF619 domain. Cartoon representation of (A) the tetramer of truncated yNAGK, as observed in the
crystal soaked with arginine (2.1 A ˚ resolution); and (B), of the hexamer of P. aeruginosa NAGK (PDB file 2BUF [7]). Two different hues of blue, green or
red were used to identify the two subunits forming each R dimer. NAG and arginine in (A), and NAG and ADP-Mg in (B) are shown in space-filling
representation. In (A) the N- and C-lobes and the secondary structure elements are labeled (helices with letters, strands with numbers) in the arginine-
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to having only one subunit with arginine and a broken symmetry.
Structure of the complete mature yNAGK
Two closely related, yet non-isomorphous crystals of full-length
mature yNAGK, each containing two enzyme tetramers in the
asymmetric unit, have allowed determination of the structure of
complete yNAGK using X-ray diffraction (Tables 1 and 2; Protein
Data Bank, PDB, (www.pdb.org) accession codes 3ZZI and 4AB7).
Although the resolution attained was 3.25 A ˚ at the most, the high
quality of the averaged electron density map (illustrated in the
Figure S3) allowed to unambiguously trace the entire polypeptide
and to identify the majority of amino acid side chains, particularly
for the DUF619 domain. The full-length enzyme tetramers consist
of the AAK domains occupying the central part of the molecule, as
in the truncated enzyme structure, flanked at both ends along the
Q axis by a pair of interacting DUF619 domains (Figures 7A and
7B). Projected along the P axis, the enzyme presents an elliptic
profile with minor (R) and major (Q) axes of 109 A ˚ and 140 A ˚,
respectively. The central hole described for the truncated enzyme
is also present, together with two narrow openings between the
DUF619 and the AAK domains (Figure 7A). The lines joining the
centers of mass of mutually interacting DUF619 domains are
oblique in relation to the flat AAK tetramer; thus DUF619
domain pairs protrude from the plane defined by the four AAK
domains (Figure 7B). The structures of the four tetramers found in
the two crystals deviate from perfect D2 molecular symmetry, with
three subunits in each tetramer exhibiting the open AAK domain
conformation. The degree of AAK domain opening is even higher
than in the arginine-containing subunit of the truncated enzyme,
corresponding to a 20u rotation of the C-lobe (Figure 8A). The
pulling of the C-lobes by the paired DUF619 domains possibly
contributes to this opening of the AAK domain, which is
associated with rotations of up to 55u of the DUF619 domain
around a hinge located at the AAK domain-DUF619 domain
linker (
351GYK) (Figure 8B). It is interesting that arginine
inhibition of Neisseria gonorrhoeae NAGS (NgNAGS) is associated
with a rotation of approximately 109u of the C-terminal domain of
this enzyme around the linker connecting it to the AAK domain
[22]. As shown below, this domain of NgNAGS corresponds to the
DUF619 domain of yNAGS.
Comparison of the complete and truncated NAGK structures
explains why the presence of the DUF619 domains does not
influence the Km values for the substrates. This lack of effect on
the apparent affinity for both substrates reflects the lack of physical
interactions of the DUF619 domains with the substrate sites,
which remain equally exposed in the structures of the truncated
(Figure 3A) and the complete enzymes (Figure 7A). In contrast, the
increase in kcat associated with the truncation parallels the
increased tendency of the AAK domains of the complete enzyme,
relative to the AAK domains of the truncated enzyme, to adopt
the open inactive conformation. The decrease in the I0.5 for
arginine upon truncation may result from the loss of the contacts
existing in the complete enzyme between the DUF619 domain
containing subunit, except helix B, which is labeled in the left-hand adjacent subunit. The 2-fold axes (labeled in (A) as P, Q and R) are shown as
broken blue lines ending in blue ellipses, and the 3-fold axis of hexameric NAGK (B) is shown as a blue triangle. Interdimeric junctions are labeled and
enclosed in broken-line rectangles in both (A) and (B). One such junction for the hexameric enzyme is enlarged in the lower inset of (B). In turn, the
intersubunit junctions in the R dimer are enclosed in dotted-line rectangles, and they are illustrated in the top insets for (A) and (B), after 90u rotation
around the R axes, relative to the main figures 3A and 3B. In the insets, elements from the two subunits are differentiated by the color code and also
by placing asterisks on the labeled elements of one subunit. (C) Stereo view of the intersubunit bonds in the R dimer involving the b5 strands and the
C-terminal moiety of helix C. This figure illustrates the b-sheet continuity across the intersubunit interface through side-chain bonds. Elements from
one subunit are yellow and those from the other are green.
doi:10.1371/journal.pone.0034734.g003
Figure 4. Size-exclusion chromatography of the complete
enzyme and its isolated domains. The bottom panel illustrates the
optical absorption (280 nm) of the effluent after injection to the
Superdex 200 column of either complete NAGK (continuous line), AAK
domain (broken line) and DUF619 domain (dotted line). The top panel
illustrates a semi-logarithmic plot of molecular mass versus elution
volume. Filledblack circles correspond to the following protein standards
(mass is given in kDa between parentheses): thyroglobulin (669), ferritin
(440), NAGS from P. aeruginosa (294), b-amylase (224), NAGK from P.
aeruginosa (191), alcohol dehydrogenase tetramer (147 kDa), bovine
serum albumin (66), alcohol dehydrogenase monomer (37) and
ribonuclease (14). Open-rimmed symbols plot the volumes of elution
of the main peak for NAGK (inverted triangle) and for its AAK domain
(square) versus their sequence-deduced masses if they were homo-
tetramers, and for the DUF619 domain (circle) if it were monomeric
(sequence-deduced masses 204, 132 and 21 kDa, respectively). Non-
rimmed gray-filled symbols plot these positions for the sequence-
deduced masses if NAGK and AAK were hexamers and if DUF619 were a
dimer. Rimmed gray symbols correspond to the minor early peaks
observed in the elution of NAGK and the AAK domain, by considering
that both are octamers (black-rimmed) or dodecamers (gray-rimmed).
doi:10.1371/journal.pone.0034734.g004
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which include interactions with the second N-helix and, in some
subunits, with the mobile loop at the end of helix H (Figure 7A),
may hamper the arginine binding site adopting a conformation
that is competent for binding the feed-back inhibitor. The
sigmoidal arginine inhibition kinetics of the complete enzyme
suggests the propagation, mediated by de paired DUF619
domains, of the changes in one arginine binding site to the
arginine binding site across the same interdimeric junction. In
agreement with this view, the Hill coefficient for arginine
inhibition kinetics for the complete enzyme is 2, whereas inhibition
of the truncated enzyme is non-sigmoidal (Figure 2D). It is
noteworthy that, in the NAGK/NAGS metabolon, these effects of
the DUF619 domain on arginine regulation are lost [15].
Therefore, binding of yNAGS to yNAGK possibly abolishes the
interactions between the NAGK DUF619 domains and the
arginine binding sites, most likely because of structural rearrange-
ments in the NAGK tetramer.
The much higher temperatures needed for unfolding the
complete yNAGK than for unfolding the truncated yNAGK
(Figure 2E) indicate structural stabilization by the presence of the
DUF619 domains, perhaps due to the pairing of these domains
and to their interactions with the AAK domains of their cognate
subunits.
The DUF619 domain presents the histone
acetyltransferase fold
The DUF619 domain is a bilobar (N-moiety, residues 354–447;
C-moiety, residues 448–502) open aba sandwich nucleated by a 7-
stranded antiparallel b-sheet, which has the characteristic
architecture of the histone acetyltransferase fold (GNAT fold)
(Figure 8C) [16]. This architecture is shared also by the
acetyltransferase domain of NgNAGS (Figure 8D), the domain
that in this enzyme binds glutamate and AcCoA and catalyzes
acetyl transfer. It includes a typical V-shaped central sheet, in
which strands 49 and 59 diverge, with strand topologies for the N-
and C-moieties of the sheet, 19293949 and 597969, respectively. The
comparison of the GNAT domains from NgNAGS and yNAGK
(with an r.m.s.d. of 2.52 A ˚ for 111 residues) explains why yNAGK
lacks NAGS activity. The AcCoA binding site in NgNAGS, found
on the boundary of the N- and C-moieties, is blocked in yNAGK
(compare Figures 8E and 8F). The CoA recognition motif R/Q-x-
x-G-x-G/A [23], which is present in NgNAGS (
364QDGGYG
369)
at the entrance of helix D9, is replaced in yNAGK by
431WLNNVT
436 (the motif-characteristic residues are underlined)
(Figure 8C). T436 replaces one glycine of the CoA binding motif.
W431, sandwiched between N460 and T436, blocks the part of
the site where the pyrophosphate moiety of the CoA molecule
would be expected to bind, thus rendering impossible AcCoA
binding (Figures 8C and 8F). In contrast, in the X. campestris
bifunctional NAGS/NAGK enzyme, the CoA recognition signa-
ture,
350QGEGLG, is preserved, therefore supporting the view
that changes in the AcCoA site correlate with the lack of NAGS
activity in yNAGK.
The pairing of the DUF619 domains on each side of the
yNAGK tetramer involves hydrophobic interactions between the
E9 and F9 helices as well as the continuity of the central b sheets by
way of antiparallel bonding of strands 69 from both domains
(Figure 8C). These interactions are maintained in the four pairs of
DUF619 domains observed in the present crystal structure (with
r.m.s.d.s from 0.85 to 1.45 A ˚), despite the important departures
from the D2 symmetry observed in the yNAGK tetramers. The
contacts among the DUF619 domains, although not strong
enough for dimer formation when the DUF619 domains are
isolated, judging from the size exclusion chromatography results
(Figure 4), could contribute ,2800 A ˚ 2 of extra buried surface in
the whole enzyme tetramer, and should, thus, substantially
contribute to tetramer stability. The plasticity of the ‘‘stands’’ at
the dimeric junctions, together with the rigidity of the pairing of
the DUF619 domains, should restrain the mobility required by the
opening/closing of the active centers in the AAK domains.
Final remarks
The present work raises questions as to why yNAGK has an
inactive GNAT domain and a distinctive tetrameric architecture.
Identification of a bifunctional NAGS/NAGK enzyme in X.
campestris, with apparently the same domain organization as
yNAGK and a high NAGS activity [14], suggests that the yeast
NAGK/NAGS metabolon could have evolved from an ancestral
bifunctional NAGS/NAGK enzyme. Loss of NAGS activity in
one component and of NAGK activity in the other may have
arisen when a cyclic arginine biosynthetic route was introduced,
downgrading the role of the NAGS activity to a merely
replenishing (anaplerotic) one (Figure 1). In this context, it appears
advantageous to separately regulate NAGS and NAGK levels by
having independent genes for these two enzymes rather than
having a single bifunctional NAGK/NAGS. To prevent deacyla-
tion of NAG by deacylases, which are abundant in animals [24]
and perhaps also in ascomycetes, the yNAGK/yNAGS metabolon
could serve to channel NAG from its production site in the GNAT
domains of yNAGS to the phosphorylation sites in the AAK
domains of yNAGK. The flat tetrameric nature of yNAGK, with
the exposure of two active centers on each face of the tetramer,
appears well suited for the association with yNAGS dimers,
assuming that the structure of yNAGS is similar to the one
determined here for yNAGK (Figure 9).
The present results may also be relevant for human NAGS,
whose inborn errors cause clinical hyperammonemia [25]. The
closeness of human and yeast NAGSs [26,27] suggests that both
share the domain composition of yNAGK [14], including the
presence of the C-terminal DUF619 domain. Therefore, the view
[25] that the hexameric structure of NgNAGS [20] may be a
model for human NAGS should be re-evaluated. In fact, the few
data available on mammalian NAGS suggest that this enzyme is a
lower oligomer than hexamers [28,29]. Nonetheless, the fact that
yNAGS, with no independent existence of yNAGK, is the closest
non animal homolog of human NAGS [14,25,26] renders it
conceivable that human NAGS might be associated with other
proteins. This may fit the low stability of the mammalian enzyme
[29]. In this context, and given the difficulties to obtain crystalline
mammalian NAGS, determination of the structure of the yeast
NAGK/NAGS complex might provide insights into the structure
of human NAGS. Therefore, efforts are being invested in our
laboratory to ascertain the structure of the yeast NAGK/NAGS
complex.
Materials and Methods
Production of yeast NAGK and its isolated AAK and
DUF619 domains
To produce yNAGK which lacks the mitochondrial targeting
sequence and is preceded by a MGH6 His-tag, the DNA sequence
encoding enzyme residues 58–513 (see Table S1) was PCR-
amplified from pYB3 [15] and inserted into the NcoI-HindIII sites
of pTrc99a (from Pharmacia; now discontinued). yNAGK was
truncated after residue 356 by replacing in the yNAGK-encoding
plasmid codon 357 by the TGA stop codon, using the site-directed
mutagenesis QuickChange kit (Stratagene), and primers 3 and 4
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amplified (Table S1) from Saccharomyces cerevisiae (strain FY250)
genomic DNA (a gift of P. Sanz, IBV-Valencia) and inserted at the
NheI/BamHI sites of pET28a. This construct fuses the His-tag
including a thrombin cleavage site,
MGSSH6SSGLVPRGSHMAS, to residue 353 of yNAGK, which
is the first of the DUF619 domain. All the constructs were verified
by automated DNA sequencing.
The complete enzyme and its AAK domain were expressed in
E. coli BL21 (DE3) grown to OD
600=0.5–0.6 (37uC, aeration) in
0.5–1 L LB medium, supplemented with 0.1 mg/ml ampicillin
and then induced for 20 hours at 30uC with 1 mM isopropyl-b-D-
1-thiogalactopyranoside (IPTG). The Se-Met-substituted AAK
domain was produced in the same way by replacing LB with
SelenoMet Medium (Molecular Dimensions, Newmarket, UK),
adding to this medium 15 min before IPTG induction an amino
acid mixture containing 60 mg/L L-Se-methionine, 100 mg/L of
each, L-lysine-HCl, L-phenylalanine and L-threonine, and
50 mg/L of each, L-isoleucine, L-valine and L-leucine [30]. The
antibiotic used for the DUF619 domain expression was kanamycin
(0.06 mg/ml), and the culture was placed for 30 min on ice before
induction with 0.02 mM IPTG, continuing the culture for
20 hours at 15uC.
Subsequent steps were performed at 4uC. After centrifugation,
cell pellets were sonicated in 1/25 of the original volume of a
solution containing 20 mM Tris-HCl pH 7.5, 10 mM MgCl2,
1 mM dithiothreitol and either 0.25 M (complete yNAGK) or
0.5 M (AAK or DUF619 domains) NaCl, and the supernatant of
the centrifuged sonicate was applied to a 1-ml HisTrap column
fitted in an A ¨KTA FPLC (from GE Healthcare). This column had
been equilibrated with the sonication buffer enriched with 20 mM
imidazole, and was washed successively with 5 ml of the same
solution and then with 15 ml of 70 mM imidazole-containing
solution. The pure proteins, eluted by increasing the imidazole
Figure 5. The yNAGK subunit and NAG binding. (A) Stereo view of the superimposition of backbone representation of EcNAGK (in green) with
bound AMPPNP and NAG (ligands shown in green sticks), and of one truncated yNAGK subunit (2.2 A ˚ resolution, black, with spheres marking every
twentieth residue) bound to NAG (in yellow). (B) The NAG site. Detailed view of the substrate site of the NAG-containing truncated yNAGK crystal
(2.2 A ˚ resolution). The protein and ligands are shown in sticks representation, with the C atoms colored green in the protein and yellow in the
ligands. The Fo-Fc electron density map calculated omitting NAG from the model (omit map) is superimposed as a red grid and contoured at 3.0 s.
Cyan spheres are water molecules. Residues involved in NAG binding and the b3–b4 hairpin are labeled. (C) Backbone representation of the
superimposition of the NAG site in two NAG-free (blue and violet) and one NAG-bound (black) subunits of truncated yNAGK, and in EcNAGK, either
NAG-free (red) or bound to NAG and AMPPNP-bound (green) (E. coli structures taken from PDB codes 2WXB [21] and 1OHA [53], respectively), to
illustrate NAG site lid mobility. Ligands (in sticks) have green-colored C atoms and yellow-colored ones for EcNAGK and yNAGK, respectively.
Secondary structure elements are labeled.
doi:10.1371/journal.pone.0034734.g005
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freed from imidazole by centrifugal ultrafiltration.
The His-tag was removed from the DUF619 domain by
overnight digestion at 4uC with agarose-inmobilized thrombin
(Thrombin Clean Cleave Kit, Sigma, USA) in 50 mM Tris-HCl
pH 8.0, 10 mM MgCl2, 10 mM CaCl2 and 0.25 M NaCl,
collecting the tag-free protein by passing through a His-trap Ni-
affinity column according to the kit instructions. Following
confirmation of tag removal by SDS-PAGE (15% gels,
Figure 2A), the protein was concentrated to ,10 mg/ml and
placed in sonication buffer for storage, as above.
For crystallization purposes, the surface-exposed lysine residues
of the complete enzyme were reductively dimethylated [31] using
a commercial kit (JBS Methylation Kit, from Jena Bioscience
GmbH, Germany), following the manufacturer’s instructions.
Then the enzyme was concentrated to ,10 mg/ml and was
placed in 20 mM Hepes, pH 7.5, 1 mM b-mercaptoethanol and
0.5 M NaCl.
Enzyme activity assays
NAGK activity was determined colorimetrically in the presence
of 0.4 M hydroxylamine [32] at 37uC. When NAG was varied,
ATP and MgCl2 were fixed at 20 mM and 30 mM, respectively.
When ATP was varied, the NAG concentration was fixed at
80 mM and that of MgCl2 was kept in 10 mM excess over that of
ATP.
NAGS activity was determined at 37uC as glutamate-triggered
CoA release from AcCoA by monitoring colorimetrically SH
group production with Ellman’s reagent [18,19]. The assay
mixture contained 0.1 M Na L-glutamate, 4 mM AcCoA and
either 0.2 M triethanolamine-HCl, pH 7.0 or 0.2 M Tris-HCl,
pH 9.0. Whenever indicated, the assay mixture was supplemented
Figure 6. Arginine binding and associated conformational changes in the yNAGK subunit. (A) Arginine binding to truncated yNAGK
(2.1 A ˚ resolution). The protein and ligands are shown in sticks representation, with the C atoms in yellow in the protein, and in green in the ligand.
The Fo-Fc omit electron density map for arginine is superimposed as a red grid, contoured at 3.0 s. This map was prepared by omitting arginine from
the model in the refinement and calculation of the map. Cyan spheres are water molecules. Residues involved in arginine binding and the second N
helix (aN2) are labeled. (B) Superimposition of the arginine-containing site (purple) with the arginine-free site (cyan) of another subunit to show
second N-helix mobility. The C-lobe central b sheet, helix H, both N-terminal helices and the side chain of Y87 are labeled. The change in the position
of the Y87 side-chain reflects the rotation of the second N-helix around its central axis (see the text). (C) Stereo view of the superimposition of the
arginine-containing subunit (blue) and of an arginine-free subunit (red) of the same tetramer (subunits C and A, respectively), revealing the 16u-
rotation of the C-lobe around the drawn axis (green broken line) and the indicated hinge residues. Bound NAG and arginine are shown in sticks.
Domain orientation is the same as in Figure 3 of [21].
doi:10.1371/journal.pone.0034734.g006
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with the enzyme and was stopped after 30 min by a 40-fold
dilution with 0.2 mM Ellman’s reagent in 0.1 M Na phosphate,
pH 7.0, determining absorbance at 412 nm.
Crystallization and data collection
Table 1 summarizes the data on the different crystals. The
sparse matrix vapor diffusion sampling approach [33] was
followed in crystallization screens at both 21uC and 4uC, in
0.8 ml sitting drops (1/1 protein solution/reservoir fluid), either
with or without additions of 24 mM NAG, 20 mM MgCl2,6m M
of the inert ATP analog adenosine 59-(b,c-imido) triphosphate
(AMPPNP) or 2 mM L-arginine-hydrochloride, added individu-
ally or as mixtures. The DUF619 domain, either with or without
His-tag, yielded no crystals. The best crystals of the truncated
enzyme (native or Se-Met substituted) had approximately 0.4 mm
largest dimension and grew in 24-well plates at 4uCi n2 - m1
hanging drops composed of 1/1 24 mM NAG-containing protein
solution/crystallization solution (50 mM Na acetate, pH 4.6,
0.2 M Na-malonate and 2% w/v PEG-8K from Hampton
Research, USA). The crystals, harvested in crystallization solution
supplemented with 25% glycerol, and, in the case of the native
NAG-containing crystals, with 2 mM HgCl2, (added aiming
initially at phasing by anomalous diffraction) were frozen in liquid
nitrogen and used for diffraction data collection at 100 K (Oxford
Cryosystems) at the ESRF synchrotron (Grenoble). One crystal
was soaked with arginine by adding 0.5 ml of 0.2 M L-arginine-
hydrochloride to the drop 24 hours before harvesting. Another
crystal was freed from NAG by successive three 2-hour passages
through 5 ml drops of NAG-free crystallization solution prior to
harvesting in the cryobuffer and freezing.
Three crystals of the complete enzyme were used for data
collection. Crystal NAGK1 belonged to one type and diffracted X-
rays at 3.1 A ˚-resolution. It grew at 4uC in sitting drops composed
of 0.4 ml of reductively methylated protein solution without ligands
and 0.4 ml crystallization solution containing 0.2 M NH4I and
20% PEG3350 (Hampton Research, USA). Crystals NAGK2 and
NAGK3 (3.8 and 3.25 A ˚- resolution, respectively) were of the same
Figure 7. Structure of complete mature yNAGK. Cartoon representation of (A) front and (B) side views of the complete enzyme. The side view
corresponds, in relation to the front view, to a 90u-rotation along the Q axis. In both views, one dimer is red and magenta and the other blue and
cyan, and the AAK and DUF619 domains of each subunit are in different hues of the same color. In the front view, the two exposed active centers on
one side of the molecule are labeled and marked with arrows, and curved broken lines separate the DUF619 domain dimers from the AAK domain
tetramer. The 2-fold axes (labeled as P, Q and R) are shown in both figures.
doi:10.1371/journal.pone.0034734.g007
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PLoS ONE | www.plosone.org 12 April 2012 | Volume 7 | Issue 4 | e34734Figure 8. The DUF619 domain. (A) and (B) Stereo views to show movements of the AAK domain C-lobe and GNAT domain. In (A), the N-lobes of
an open (red) and a closed (blue) subunit of the complete enzyme are superimposed, whereas in (B), the AAK-domain N-lobe is not shown and the C-
lobes of this domain of both subunits are superimposed, illustrating the 55u-rotation associated with subunit opening (red), with the axis of the
rotation shown as a green broken line. (C) The DUF619 domain dimer. Each subunit is in a different color (a helices red or magenta, b sheets yellow or
green, with loops in blue in both subunits). Secondary structure elements are labeled in the subunit on the right. The side-chains of W431, T436 and
N460 (in cyan or blue), which block the AcCoA channel, are shown in this subunit and are labeled. (D) Superimposition of the backbone of the GNAT
domains of yNAGK (black, with every twentieth residue marked with a sphere and labeled) and of NgNAGS (green) (PDB code 3D2M [22]). The CoA
and glutamate, found in the latter structure, are illustrated in sticks representation with C atoms in yellow. (E) and (F) Comparison of the AcCoA site of
NgNAGS (E) in surface representation, with bound CoA in spheres, and the corresponding region of yNAGK (F), in the same orientation, showing the
side chains of W431, T436 and N460 in spheres representation to illustrate the blocking of the AcCoA channel by these side chains.
doi:10.1371/journal.pone.0034734.g008
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NAG using a crystallization solution containing 0.2 M ammonium
citrate pH 7.0 and 12% PEG3350 (and 1.5% PEG6000 as an
additive for crystal 3). Crystallization solutions with PEG3350
concentration raised to 40% were used as a cryobuffer for liquid
nitrogen freezing.
The data for the crystals of the truncated enzyme were
processed with MOSFLM [34] or XDS [35], SCALA [36], and
TRUNCATE [37] (Table 1). The orthorhombic cell (space group
P212121) contained four subunits in the asymmetric unit and 49%
solvent content (Table 1). Crystal NAGK1 of the complete enzyme
had a monoclinic cell (space group C2) with two subunits in the
asymmetric unit, whereas crystals 2 and 3 had triclinic cells (space
group P1), with eight subunits in the asymmetric unit.
Structure determination and refinement
Table 2 summarizes refinement and model data statistics. The
initial single-wavelength (0.979 A ˚) anomalous diffraction (SAD)
phases for the Se atoms of the Se-Met AAK crystal diffracting to
3.4 A ˚ resolution, obtained with ShelxC/D/E [38], were improved
by refining the Se atom positions with the SAD phasing mode of
PHASER [39], implementing density modification, histogram
matching, solvent flattening and density averaging with the
program DM [40]. A partial model without side chains was built
and used successfully as a search model to obtain initial phases by
molecular replacement with MOLREP [41] in a 2.2 A ˚ dataset
from the NAG-containing crystal. Rigid body refinement was
performed stepwise with increasing resolution, followed by
restrained refinement using REFMAC [42], alternating with
interactive graphic modeling using COOT [43]. The model
encompassed all the residues of each subunit, except for the His-
tag and four-five N-terminal and C-terminal residues, and it also
included one NAG molecule and two Hg atoms per chain sitting
next to the S atoms of two Cys residues. B-factors and positional
non crystallographic symmetry restraints were used and gradually
released as refinement progressed. All the diffraction data were
used throughout the refinement process, except for the 5%
randomly selected data used for calculating Rfree. TLS (transla-
tion/libration/screw) [44] was applied in the final refinement steps
with the TLSMD server for the definition of the TLS groups [45].
The structure obtained in this way to 2.2 A ˚ resolution was used as
a search model for molecular replacement with MOLREP to
obtain phases for the crystals of the truncated enzyme without
ligands or soaked with arginine. Refinement for these crystals was
carried out as described for the NAG-containing structure
(Table 2).
For the complete enzyme, initial phases were obtained for the
3.1 A ˚ dataset collected from the NAGK1 crystal by molecular
replacement with PHASER using one subunit of the truncated
enzyme as search model to yield a dimer in the asymmetric unit.
As refinement progressed, electron density became clearer for the
DUF619 domain of the two subunits, and a partial model (about
75% of the domain main-chain) was built. This incomplete
NAGK1 model was then used to obtain an initial solution for the
NAGK2 crystal by molecular replacement with MOLREP,
consisting of 4 dimers forming two tetramers in the asymmetric
unit. Further phase improvement was achieved by density
averaging between the NAGK crystals 1 and 2, using DMMULTI
of the CCP4 suite [46] in conjunction with non crystallographic
symmetry averaging, solvent flattening and histogram matching
for each crystal. The complete NAGK model was then built for
each subunit (except for the 9 initial and the 11 terminal residues)
in the two crystals. Refinement could then be carried out until the
appropriate quality indicators were obtained for the NAGK2
structure (Table 2). However, refinement was not completed for
NAGK1, which is likely to be due to the presence of some unsolved
twinning which was apparent during data collection. Refinement
for NAGK2 was done by always maintaining tight non
crystallographic symmetry restraints and 6 TLS groups per
subunit in the final steps. Despite the low resolution (3.8 A ˚), the
quality of the maps allowed the recognition of most of the side
chains in the DUF619 domain. The third dataset, collected to
3.25 A ˚ resolution (Table 2) solved by molecular replacement
(using the complete subunit of the NAGK2 crystal as the model),
yielded eight subunits in the asymmetric unit forming two
tetramers. The model, including two NAG molecules, was built
and refined to 3.25 A ˚ resolution, as for the NAGK2 crystal, except
for the N-terminal helix of four subunits (two per tetramer at the
interdimeric junction), which presented poor density.
The final models for the crystals of the truncated enzyme
without NAG, with NAG, and with arginine, and of the complete
NAGK2 and NAGK3 crystals, yielded good Rfactor/Rfree values
and showed good stereochemistry (monitored with PROCHECK)
[47]. Superposition of the structures and the r.m.s.d. calculations
were carried out with LSQKAB program [48] using default
parameters. The buried surface areas and contacts between the
subunits were calculated with a probe of 1.4 A ˚ radius using PISA
[49]. Subdomain movements were analyzed with DynDom [50].
Figures of protein structures were drawn using PyMOL (http://
www.pymol.org).
Other methods
Thermal stability was assessed with the thermofluor approach
[17] in 96-well sealed plates using a real-time PCR system
Figure 9. Model of the yeast NAGK/NAGS complex. Crude model
of the proposed architecture of the complex of yNAGK and yNAGS.
Given the similarity of yNAGK and yNAGS, the latter has been
represented as one of the yNAGK dimers observed in the present
structures, superimposing the CoA and glutamate observed in the
structure of the corresponding domain of NgNAGS in the GNAT domain
to illustrate the nearness of the NAG site to the active centers that are
exposed on one side of the yNAGK tetramer (labeled). Since another
dimer of the yNAGS dimer would sit on the other flat face of the yNAGK
tetramer, the complex stoichiometry for complete occupation of yNAGK
by yNAGS would be 4:4 in terms of number of subunits of both
proteins. No attempt has been made to model the interactions
between the GNAT domains of both proteins.
doi:10.1371/journal.pone.0034734.g009
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(Invitrogen, USA) fluorescence with gradual temperature increase
(1uC/min). The 20-ml samples contained 0.2 mg/ml protein in
0.1 M Hepes pH 7.5, 0.15 M NaCl, Sypro Orange (1:1000
dilution), and 50 mM L-arginine whenever indicated. The
unfolded protein fraction was estimated as the ratio between
fluorescence increase at a given temperature and the maximal
increase observed (complete unfolding). T0.5 is the temperature
giving a fluorescence increase corresponding to 50% of the
maximum increase.
Analytical size exclusion chromatography through Superdex
200 (10/300 column from GE Healthcare) was carried out at
24uC, as reported elsewhere [3], in 50 mM Hepes pH 7.5/0.25 M
NaCl. Protein concentration was determined according to
Bradford [51] using bovine serum albumin as a standard.
Accession numbers
The atomic coordinates and structure factors of yNAGK
lacking the DUF619 domain, complexed with NAG (PDB ID:
3ZZF), NAG and arginine (PDB ID: 3ZZH), or ligand-free (PDB
ID: 3ZZG), as well as those of the complete enzyme (PDB ID:
3ZZI and 4AB7), have been deposited in the Protein Data Bank
(www.pdb.org).
Supporting Information
Figure S1 Comparison of the dimers of the AAK domain
of yNAGK (A) and EcNAGK (B). In both dimers, the subunit
on the left (lighter) is fixed in the same orientation, to highlight the
different relative orientation of the other subunit in both NAGKs,
in relation to the fixed subunit. The N-terminal ‘‘stand’’ of
yNAGK has been omitted for clarity.
(TIF)
Figure S2 Stereo view of the interactions of one ‘‘stand’’
with its subunit body (both brown) and with the other
‘‘stand’’ (pink) across the interdimeric junction.
(TIF)
Figure S3 Experimental information for the DUF619
domain. (A) Stereo views of the 2Fo-Fc (blue grid) and Fo-Fc (red
grid) electron density maps of the complete DUF619 domain
(shown as Ca), contoured at 1.0 and 2.5 s, respectively. (B)
Detailed view of a region of the domain, with the model in sticks
representation (yellow, blue and red, carbon, nitrogen and oxygen
atoms, respectively), to illustrate that the map quality allows
identifying most amino acid side chains (labelled for some
residues).
(TIF)
Table S1 Oligonucleotides used in cloning and site-
directed mutagenesis.
(DOC)
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